 | • レポートコード：QYR2104Z1131 • 出版社/出版日：QYResearch / 2021年4月15日 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、心肺用自動輸血システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（未洗浄ATS、洗浄ATS）、用途別市場規模（心臓手術、臓器移植手術、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・心肺用自動輸血システムの市場動向 ・企業の競争状況、市場シェア ・心肺用自動輸血システムの種類別市場規模（未洗浄ATS、洗浄ATS） ・心肺用自動輸血システムの用途別市場規模（心臓手術、臓器移植手術、その他） ・心肺用自動輸血システムの北米市場規模2016-2027（アメリカ、カナダ） ・心肺用自動輸血システムのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・心肺用自動輸血システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心肺用自動輸血システムの中南米市場規模2016-2027（メキシコ、ブラジル） ・心肺用自動輸血システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Advancis Surgical、Fresenius Kabi、Haemonetics、LivaNova、Medtronic、Terumo、Atrium Medical、Global Blood Resources、Redax、Sarstedt、Stryker） ・結論 |
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood.
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.
Market Analysis and Insights: Global Cardiopulmonary Autotransfusion Systems Market
The global Cardiopulmonary Autotransfusion Systems market size is projected to reach US$ 600.5 million by 2026, from US$ 525.6 million in 2019, at a CAGR of 1.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiopulmonary Autotransfusion Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiopulmonary Autotransfusion Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiopulmonary Autotransfusion Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiopulmonary Autotransfusion Systems market.
Global Cardiopulmonary Autotransfusion Systems Scope and Market Size
Cardiopulmonary Autotransfusion Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Autotransfusion Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Market by Application
1.3.1 Global Cardiopulmonary Autotransfusion Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cardiopulmonary Autotransfusion Systems Market Perspective (2016-2027)
2.2 Cardiopulmonary Autotransfusion Systems Growth Trends by Regions
2.2.1 Cardiopulmonary Autotransfusion Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cardiopulmonary Autotransfusion Systems Historic Market Share by Regions (2016-2021)
2.2.3 Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Regions (2022-2027)
2.3 Cardiopulmonary Autotransfusion Systems Industry Dynamic
2.3.1 Cardiopulmonary Autotransfusion Systems Market Trends
2.3.2 Cardiopulmonary Autotransfusion Systems Market Drivers
2.3.3 Cardiopulmonary Autotransfusion Systems Market Challenges
2.3.4 Cardiopulmonary Autotransfusion Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiopulmonary Autotransfusion Systems Players by Revenue
3.1.1 Global Top Cardiopulmonary Autotransfusion Systems Players by Revenue (2016-2021)
3.1.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Players (2016-2021)
3.2 Global Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cardiopulmonary Autotransfusion Systems Revenue
3.4 Global Cardiopulmonary Autotransfusion Systems Market Concentration Ratio
3.4.1 Global Cardiopulmonary Autotransfusion Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiopulmonary Autotransfusion Systems Revenue in 2020
3.5 Cardiopulmonary Autotransfusion Systems Key Players Head office and Area Served
3.6 Key Players Cardiopulmonary Autotransfusion Systems Product Solution and Service
3.7 Date of Enter into Cardiopulmonary Autotransfusion Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiopulmonary Autotransfusion Systems Breakdown Data by Type
4.1 Global Cardiopulmonary Autotransfusion Systems Historic Market Size by Type (2016-2021)
4.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Type (2022-2027)
5 Cardiopulmonary Autotransfusion Systems Breakdown Data by Application
5.1 Global Cardiopulmonary Autotransfusion Systems Historic Market Size by Application (2016-2021)
5.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cardiopulmonary Autotransfusion Systems Market Size (2016-2027)
6.2 North America Cardiopulmonary Autotransfusion Systems Market Size by Type
6.2.1 North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021)
6.2.2 North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027)
6.2.3 North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2027)
6.3 North America Cardiopulmonary Autotransfusion Systems Market Size by Application
6.3.1 North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021)
6.3.2 North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027)
6.3.3 North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2027)
6.4 North America Cardiopulmonary Autotransfusion Systems Market Size by Country
6.4.1 North America Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021)
6.4.2 North America Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cardiopulmonary Autotransfusion Systems Market Size (2016-2027)
7.2 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type
7.2.1 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021)
7.2.2 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027)
7.2.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2027)
7.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application
7.3.1 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021)
7.3.2 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027)
7.3.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2027)
7.4 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country
7.4.1 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021)
7.4.2 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size (2016-2027)
8.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Type
8.2.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Application
8.3.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region
8.4.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size (2016-2027)
9.2 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type
9.2.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021)
9.2.2 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027)
9.2.3 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2027)
9.3 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application
9.3.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021)
9.3.2 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027)
9.3.3 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2027)
9.4 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country
9.4.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021)
9.4.2 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size (2016-2027)
10.2 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Type
10.2.1 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Application
10.3.1 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Country
10.4.1 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advancis Surgical
11.1.1 Advancis Surgical Company Details
11.1.2 Advancis Surgical Business Overview
11.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Introduction
11.1.4 Advancis Surgical Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.1.5 Advancis Surgical Recent Development
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Introduction
11.2.4 Fresenius Kabi Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.2.5 Fresenius Kabi Recent Development
11.3 Haemonetics
11.3.1 Haemonetics Company Details
11.3.2 Haemonetics Business Overview
11.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Introduction
11.3.4 Haemonetics Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.3.5 Haemonetics Recent Development
11.4 LivaNova
11.4.1 LivaNova Company Details
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Introduction
11.4.4 LivaNova Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.4.5 LivaNova Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Introduction
11.5.4 Medtronic Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Terumo
11.6.1 Terumo Company Details
11.6.2 Terumo Business Overview
11.6.3 Terumo Cardiopulmonary Autotransfusion Systems Introduction
11.6.4 Terumo Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.6.5 Terumo Recent Development
11.7 Atrium Medical
11.7.1 Atrium Medical Company Details
11.7.2 Atrium Medical Business Overview
11.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Introduction
11.7.4 Atrium Medical Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.7.5 Atrium Medical Recent Development
11.8 Global Blood Resources
11.8.1 Global Blood Resources Company Details
11.8.2 Global Blood Resources Business Overview
11.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Introduction
11.8.4 Global Blood Resources Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.8.5 Global Blood Resources Recent Development
11.9 Redax
11.9.1 Redax Company Details
11.9.2 Redax Business Overview
11.9.3 Redax Cardiopulmonary Autotransfusion Systems Introduction
11.9.4 Redax Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.9.5 Redax Recent Development
11.10 Sarstedt
11.10.1 Sarstedt Company Details
11.10.2 Sarstedt Business Overview
11.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Introduction
11.10.4 Sarstedt Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.10.5 Sarstedt Recent Development
11.11 Stryker
11.11.1 Stryker Company Details
11.11.2 Stryker Business Overview
11.11.3 Stryker Cardiopulmonary Autotransfusion Systems Introduction
11.11.4 Stryker Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
11.11.5 Stryker Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Unwashed ATS
Table 3. Key Players of Washed ATS
Table 4. Global Cardiopulmonary Autotransfusion Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cardiopulmonary Autotransfusion Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cardiopulmonary Autotransfusion Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions (2016-2021)
Table 8. Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions (2022-2027)
Table 10. Cardiopulmonary Autotransfusion Systems Market Trends
Table 11. Cardiopulmonary Autotransfusion Systems Market Drivers
Table 12. Cardiopulmonary Autotransfusion Systems Market Challenges
Table 13. Cardiopulmonary Autotransfusion Systems Market Restraints
Table 14. Global Cardiopulmonary Autotransfusion Systems Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cardiopulmonary Autotransfusion Systems Market Share by Players (2016-2021)
Table 16. Global Top Cardiopulmonary Autotransfusion Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2020)
Table 17. Ranking of Global Top Cardiopulmonary Autotransfusion Systems Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cardiopulmonary Autotransfusion Systems Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cardiopulmonary Autotransfusion Systems Product Solution and Service
Table 21. Date of Enter into Cardiopulmonary Autotransfusion Systems Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2016-2021)
Table 25. Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cardiopulmonary Autotransfusion Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2016-2021)
Table 29. Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Country (2022-2027) & (US$ Million)
Table 61. Advancis Surgical Company Details
Table 62. Advancis Surgical Business Overview
Table 63. Advancis Surgical Cardiopulmonary Autotransfusion Systems Product
Table 64. Advancis Surgical Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 65. Advancis Surgical Recent Development
Table 66. Fresenius Kabi Company Details
Table 67. Fresenius Kabi Business Overview
Table 68. Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product
Table 69. Fresenius Kabi Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 70. Fresenius Kabi Recent Development
Table 71. Haemonetics Company Details
Table 72. Haemonetics Business Overview
Table 73. Haemonetics Cardiopulmonary Autotransfusion Systems Product
Table 74. Haemonetics Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 75. Haemonetics Recent Development
Table 76. LivaNova Company Details
Table 77. LivaNova Business Overview
Table 78. LivaNova Cardiopulmonary Autotransfusion Systems Product
Table 79. LivaNova Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 80. LivaNova Recent Development
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Cardiopulmonary Autotransfusion Systems Product
Table 84. Medtronic Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 85. Medtronic Recent Development
Table 86. Terumo Company Details
Table 87. Terumo Business Overview
Table 88. Terumo Cardiopulmonary Autotransfusion Systems Product
Table 89. Terumo Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 90. Terumo Recent Development
Table 91. Atrium Medical Company Details
Table 92. Atrium Medical Business Overview
Table 93. Atrium Medical Cardiopulmonary Autotransfusion Systems Product
Table 94. Atrium Medical Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 95. Atrium Medical Recent Development
Table 96. Global Blood Resources Company Details
Table 97. Global Blood Resources Business Overview
Table 98. Global Blood Resources Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 99. Global Blood Resources Recent Development
Table 100. Redax Company Details
Table 101. Redax Business Overview
Table 102. Redax Cardiopulmonary Autotransfusion Systems Product
Table 103. Redax Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 104. Redax Recent Development
Table 105. Sarstedt Company Details
Table 106. Sarstedt Business Overview
Table 107. Sarstedt Cardiopulmonary Autotransfusion Systems Product
Table 108. Sarstedt Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 109. Sarstedt Recent Development
Table 110. Stryker Company Details
Table 111. Stryker Business Overview
Table 112. Stryker Cardiopulmonary Autotransfusion Systems Product
Table 113. Stryker Revenue in Cardiopulmonary Autotransfusion Systems Business (2016-2021) & (US$ Million)
Table 114. Stryker Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiopulmonary Autotransfusion Systems Market Share by Type: 2020 VS 2027
Figure 2. Unwashed ATS Features
Figure 3. Washed ATS Features
Figure 4. Global Cardiopulmonary Autotransfusion Systems Market Share by Application: 2020 VS 2027
Figure 5. Heart Surgery Case Studies
Figure 6. Great Organ Transplant Surgery Case Studies
Figure 7. Others Case Studies
Figure 8. Cardiopulmonary Autotransfusion Systems Report Years Considered
Figure 9. Global Cardiopulmonary Autotransfusion Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cardiopulmonary Autotransfusion Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions: 2020 VS 2027
Figure 12. Global Cardiopulmonary Autotransfusion Systems Market Share by Regions (2022-2027)
Figure 13. Global Cardiopulmonary Autotransfusion Systems Market Share by Players in 2020
Figure 14. Global Top Cardiopulmonary Autotransfusion Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cardiopulmonary Autotransfusion Systems Revenue in 2020
Figure 16. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2016-2021)
Figure 17. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2022-2027)
Figure 18. North America Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cardiopulmonary Autotransfusion Systems Market Share by Type (2016-2027)
Figure 20. North America Cardiopulmonary Autotransfusion Systems Market Share by Application (2016-2027)
Figure 21. North America Cardiopulmonary Autotransfusion Systems Market Share by Country (2016-2027)
Figure 22. United States Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cardiopulmonary Autotransfusion Systems Market Share by Type (2016-2027)
Figure 26. Europe Cardiopulmonary Autotransfusion Systems Market Share by Application (2016-2027)
Figure 27. Europe Cardiopulmonary Autotransfusion Systems Market Share by Country (2016-2027)
Figure 28. Germany Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Share by Region (2016-2027)
Figure 38. China Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cardiopulmonary Autotransfusion Systems Market Share by Type (2016-2027)
Figure 46. Latin America Cardiopulmonary Autotransfusion Systems Market Share by Application (2016-2027)
Figure 47. Latin America Cardiopulmonary Autotransfusion Systems Market Share by Country (2016-2027)
Figure 48. Mexico Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Share by Country (2016-2027)
Figure 54. Turkey Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cardiopulmonary Autotransfusion Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Advancis Surgical Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 58. Fresenius Kabi Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 59. Haemonetics Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 60. LivaNova Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 62. Terumo Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 63. Atrium Medical Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 64. Global Blood Resources Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 65. Redax Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 66. Sarstedt Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 67. Stryker Revenue Growth Rate in Cardiopulmonary Autotransfusion Systems Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed